$ALTO
Alto Ingredients, Inc.

2023 Q3 Form 10-Q Financial Statement

#000121390023064551 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $318.1M $317.3M
YoY Change -5.57% -12.39%
Cost Of Revenue $314.0M $300.1M
YoY Change -11.98% -15.06%
Gross Profit $4.161M $17.18M
YoY Change -120.97% 94.27%
Gross Profit Margin 1.31% 5.41%
Selling, General & Admin $8.488M $7.911M
YoY Change 14.66% -12.06%
% of Gross Profit 203.99% 46.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.640M $5.680M
YoY Change -9.9% -15.58%
% of Gross Profit 135.54% 33.06%
Operating Expenses $8.488M $7.911M
YoY Change 14.66% -12.06%
Operating Profit -$4.327M $9.270M
YoY Change -84.12% -6198.68%
Interest Expense -$2.000M -$1.734M
YoY Change 488.24% 443.57%
% of Operating Profit -18.71%
Other Income/Expense, Net $26.00K $59.00K
YoY Change -105.7% -189.39%
Pretax Income -$3.489M $7.595M
YoY Change -87.56% -65.66%
Income Tax
% Of Pretax Income
Net Earnings -$3.489M $7.595M
YoY Change -87.56% -65.66%
Net Earnings / Revenue -1.1% 2.39%
Basic Earnings Per Share -$0.05 $0.10
Diluted Earnings Per Share -$0.05 $0.10
COMMON SHARES
Basic Shares Outstanding 75.91M shares 76.11M shares
Diluted Shares Outstanding 73.19M shares 74.10K shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.20M $22.74M
YoY Change -7.93% -60.37%
Cash & Equivalents $26.16M $22.74M
Short-Term Investments
Other Short-Term Assets $6.213M $5.919M
YoY Change -30.7% -46.58%
Inventory $57.09M $71.12M
Prepaid Expenses
Receivables $66.07M $63.37M
Other Receivables $0.00 $0.00
Total Short-Term Assets $168.2M $179.5M
YoY Change -9.72% -34.36%
LONG-TERM ASSETS
Property, Plant & Equipment $248.9M $246.7M
YoY Change 6.6% 10.65%
Goodwill $5.970M $5.970M
YoY Change 0.0% 1.05%
Intangibles $8.645M $8.792M
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.013M $5.993M
YoY Change -11.42% 7.17%
Total Long-Term Assets $292.9M $291.9M
YoY Change 9.14% 13.21%
TOTAL ASSETS
Total Short-Term Assets $168.2M $179.5M
Total Long-Term Assets $292.9M $291.9M
Total Assets $461.1M $471.4M
YoY Change 1.42% -11.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.99M $25.93M
YoY Change 37.14% 20.74%
Accrued Expenses $16.64M $15.33M
YoY Change -24.93% -28.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.42M $58.69M
YoY Change 7.16% -38.31%
LONG-TERM LIABILITIES
Long-Term Debt $75.88M $82.08M
YoY Change 65.35% 56.29%
Other Long-Term Liabilities $8.870M $8.791M
YoY Change -11.9% -14.55%
Total Long-Term Liabilities $84.75M $90.87M
YoY Change 51.45% 44.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.42M $58.69M
Total Long-Term Liabilities $84.75M $90.87M
Total Liabilities $163.1M $170.6M
YoY Change 36.3% 1.72%
SHAREHOLDERS EQUITY
Retained Earnings -$744.6M -$740.8M
YoY Change 6.19% 10.1%
Common Stock $76.00K $76.00K
YoY Change 2.7% 2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $298.0M $300.8M
YoY Change
Total Liabilities & Shareholders Equity $461.1M $471.4M
YoY Change 1.42% -11.28%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$3.489M $7.595M
YoY Change -87.56% -65.66%
Depreciation, Depletion And Amortization $5.640M $5.680M
YoY Change -9.9% -15.58%
Cash From Operating Activities $23.13M $10.44M
YoY Change -222.67% 8.43%
INVESTING ACTIVITIES
Capital Expenditures $6.640M $8.366M
YoY Change -142.92% -212.63%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.640M -$8.366M
YoY Change 803.4% 12.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.720M -3.423M
YoY Change -70.44% -127.27%
NET CHANGE
Cash From Operating Activities 23.13M 10.44M
Cash From Investing Activities -6.640M -8.366M
Cash From Financing Activities -6.720M -3.423M
Net Change In Cash 9.770M -1.346M
YoY Change -123.08% -109.12%
FREE CASH FLOW
Cash From Operating Activities $23.13M $10.44M
Capital Expenditures $6.640M $8.366M
Free Cash Flow $16.49M $2.077M
YoY Change -587.29% -87.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15062000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21467
dei Entity Registrant Name
EntityRegistrantName
ALTO INGREDIENTS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-2170618
dei Entity Address Address Line1
EntityAddressAddressLine1
1300 South Second Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Pekin
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
61554
dei City Area Code
CityAreaCode
(916)
dei Local Phone Number
LocalPhoneNumber
403-2123
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
ALTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75911374 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22739000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
2351000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
59000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63367000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
71115000 usd
CY2023Q2 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
14038000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5919000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
179529000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
246693000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24433000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8792000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
5970000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5993000 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
45188000 usd
CY2023Q2 us-gaap Assets
Assets
471410000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
25933000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15328000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3914000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3849000 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8396000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5115000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
58686000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
82082000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21058000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8791000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
170617000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
18075000 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75923000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75923000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
76000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1039735000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1822000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-740841000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
300793000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
471410000 usd
CY2023Q2 us-gaap Revenues
Revenues
317297000 usd
CY2022Q2 us-gaap Revenues
Revenues
362189000 usd
us-gaap Revenues
Revenues
631188000 usd
us-gaap Revenues
Revenues
670307000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
300116000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
353345000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
617171000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
656690000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
17181000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
8844000 usd
us-gaap Gross Profit
GrossProfit
14017000 usd
us-gaap Gross Profit
GrossProfit
13617000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7911000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8996000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15793000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16625000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
574000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9270000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-152000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2350000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3008000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1734000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-319000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3299000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-519000 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
22652000 usd
us-gaap Interest Income Other
InterestIncomeOther
22652000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-66000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
388000 usd
CY2023Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7595000 usd
CY2022Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
22115000 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-5571000 usd
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
19513000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7595000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
22115000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5571000 usd
us-gaap Net Income Loss
NetIncomeLoss
19513000 usd
CY2023Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
315000 usd
CY2022Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
315000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
627000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
627000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
96000 usd
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
284000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
251000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7184000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21516000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6198000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18635000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73394 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72936 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73603 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71690 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74103 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73123 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73603 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71958 shares
us-gaap Net Income Loss
NetIncomeLoss
-5571000 usd
us-gaap Net Income Loss
NetIncomeLoss
19513000 usd
us-gaap Depreciation
Depreciation
11735000 usd
us-gaap Depreciation
Depreciation
12862000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5174000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
21936000 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
3010000 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-574000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1711000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1779000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
494000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
37000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
397000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-46000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
66000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5334000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
393000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4487000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14729000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-3565000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-3210000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2566000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2528000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18870000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
19804000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12904000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20695000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17968000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9762000 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
14766000 usd
alto Deferred Purchase Price Payments For Eagle Alcohol
DeferredPurchasePricePaymentsForEagleAlcohol
3500000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14655000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21468000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9651000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
13247000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2195000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2683000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
627000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
627000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9937000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1568000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24435000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12612000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49525000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62125000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25090000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74737000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22739000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57376000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
2351000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
17361000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
25090000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
74737000 usd
us-gaap Interest Paid Net
InterestPaidNet
3964000 usd
us-gaap Interest Paid Net
InterestPaidNet
456000 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
1615000 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
87000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
308089000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
752000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-6000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1682000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
312000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-13166000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
293675000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
959000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-120000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1001000 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
315000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7595000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
300793000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
345214000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
673000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-9000 usd
CY2022Q1 alto Shares Issued To Orion
SharesIssuedToOrion
1000 usd
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
312000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2602000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
342965000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1106000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2283000 usd
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
315000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
7595000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
22115000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
363588000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
350000000 usd
CY2023Q2 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
1600000 usd
us-gaap Accounts Receivable Sale
AccountsReceivableSale
52732000 usd
CY2022 us-gaap Accounts Receivable Sale
AccountsReceivableSale
55667000 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
59000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
105000 usd
CY2023Q2 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
7000 usd
CY2022Q2 alto Bad Debt Expense
BadDebtExpense
35000 usd
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
46000 usd
alto Bad Debt Expense
BadDebtExpense
66000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
22115000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5571000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
19513000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5681000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6728000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11735000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12862000 usd
CY2023Q2 us-gaap Interest Expense Capital Securities
InterestExpenseCapitalSecurities
1734000 usd
CY2022Q2 us-gaap Interest Expense Capital Securities
InterestExpenseCapitalSecurities
319000 usd
us-gaap Interest Expense Capital Securities
InterestExpenseCapitalSecurities
3299000 usd
us-gaap Interest Expense Capital Securities
InterestExpenseCapitalSecurities
519000 usd
CY2022Q3 alto Repurchase Of Common Stock
RepurchaseOfCommonStock
50000000 usd
CY2022Q3 alto Excess Amount Of Initial Purchase
ExcessAmountOfInitialPurchase
10000000 usd
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 usd
alto Purchase Authorization Additional Lender Value
PurchaseAuthorizationAdditionalLenderValue
5000000 usd
alto Purchase Additional Amount
PurchaseAdditionalAmount
10000000 usd
CY2023Q2 alto Repurchased Aggregate Shares
RepurchasedAggregateShares
389000 shares
alto Repurchased Aggregate Shares
RepurchasedAggregateShares
1249000 shares
CY2023Q2 alto Repurchased An Aggregate Shares In Cash
RepurchasedAnAggregateSharesInCash
1001000 usd
alto Repurchased An Aggregate Shares In Cash
RepurchasedAnAggregateSharesInCash
2683000 usd
CY2023Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1600000 shares
CY2023Q2 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
4008000 usd
CY2022Q4 us-gaap Cash
Cash
22652000 usd
CY2022 alto Loan Advance
LoanAdvance
700000000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
17181000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
8844000 usd
us-gaap Gross Profit
GrossProfit
14017000 usd
us-gaap Gross Profit
GrossProfit
13617000 usd
CY2023Q2 us-gaap Assets
Assets
471410000 usd
CY2022Q4 us-gaap Assets
Assets
478321000 usd
CY2023Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
0 usd
CY2022Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
4612000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
45089000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
47736000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
7185000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6396000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
17415000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
11197000 usd
CY2023Q2 us-gaap Other Inventory
OtherInventory
1426000 usd
CY2022Q4 us-gaap Other Inventory
OtherInventory
1299000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
71115000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
66628000 usd
CY2023Q2 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
6951000 usd
CY2022Q2 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
16619000 usd
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
5174000 usd
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
21936000 usd
alto Type Of Instrument Cash Collateral Balance
TypeOfInstrumentCashCollateralBalance
Cash collateral balance
alto Assets Balance Sheet Location Restricted Cashs
AssetsBalanceSheetLocationRestrictedCashs
Restricted cash
CY2023Q2 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
2351000 usd
alto Type Of Instrument Commodity Contracts1
TypeOfInstrumentCommodityContracts1
Commodity contracts
alto Assets Balance Sheet Location Derivatives Assets
AssetsBalanceSheetLocationDerivativesAssets
Derivative instruments
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
14038000 usd
alto Liabilities Balance Sheet Location Derivative Liabilities
LiabilitiesBalanceSheetLocationDerivativeLiabilities
Derivative instruments
CY2023Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
8396000 usd
CY2022 alto Type Of Instrument Cash Collateral Balance
TypeOfInstrumentCashCollateralBalance
Cash collateral balance
CY2022 alto Assets Balance Sheet Location Restricted Cashs
AssetsBalanceSheetLocationRestrictedCashs
Restricted cash
CY2022Q4 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
13069000 usd
CY2022 alto Type Of Instrument Commodity Contracts1
TypeOfInstrumentCommodityContracts1
Commodity contracts
CY2022 alto Assets Balance Sheet Location Derivatives Assets
AssetsBalanceSheetLocationDerivativesAssets
Derivative instruments
CY2022Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
4973000 usd
CY2022 alto Liabilities Balance Sheet Location Derivative Liabilities
LiabilitiesBalanceSheetLocationDerivativeLiabilities
Derivative instruments
CY2022Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
6732000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
91323000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
78076000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4297000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4686000 usd
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4944000 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5034000 usd
CY2023Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
82082000 usd
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
68356000 usd
CY2023Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
49400000 usd
CY2023Q2 us-gaap Long Term Construction Loan Current
LongTermConstructionLoanCurrent
40000000 usd
CY2023Q2 us-gaap Significant Supply Commitment Remaining Minimum Amount Committed
SignificantSupplyCommitmentRemainingMinimumAmountCommitted
12075000 usd
alto Indexed Price Purchase Contracts
IndexedPricePurchaseContracts
113000 pure
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
17419000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21661000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7595000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
315000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-96000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7184000 usd
CY2023Q2 alto Income Available To Common Stockholders Shares Denominator
IncomeAvailableToCommonStockholdersSharesDenominator
73394 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.1
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
709 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7184000 usd
CY2023Q2 alto Income Available To Common Stockholders Diluted Shares Denominatorin Shares
IncomeAvailableToCommonStockholdersDilutedSharesDenominatorinShares
74103 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.1
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
22115000 usd
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
315000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-284000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21516000 usd
CY2022Q2 alto Income Available To Common Stockholders Shares Denominator
IncomeAvailableToCommonStockholdersSharesDenominator
72936 shares
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.29
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
187 shares
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21516000 usd
CY2022Q2 alto Income Available To Common Stockholders Diluted Shares Denominatorin Shares
IncomeAvailableToCommonStockholdersDilutedSharesDenominatorinShares
73123 shares
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.29
us-gaap Net Income Loss
NetIncomeLoss
-5571000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
627000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6198000 usd
alto Income Available To Common Stockholders Shares Denominator
IncomeAvailableToCommonStockholdersSharesDenominator
73603 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
us-gaap Net Income Loss
NetIncomeLoss
19513000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
627000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-251000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18635000 usd
alto Income Available To Common Stockholders Shares Denominator
IncomeAvailableToCommonStockholdersSharesDenominator
71690 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.26
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
268 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18635000 usd
alto Income Available To Common Stockholders Diluted Shares Denominatorin Shares
IncomeAvailableToCommonStockholdersDilutedSharesDenominatorinShares
71958 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.26
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
981000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
981000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
964000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
964000 shares
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
usd
alto Deferred Purchase Price Payments For Eagle Alcohol
DeferredPurchasePricePaymentsForEagleAlcohol
usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
alto Liabilities Balance Sheet Location
LiabilitiesBalanceSheetLocation
CY2023Q2 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
usd
CY2022 alto Liabilities Balance Sheet Location
LiabilitiesBalanceSheetLocation
CY2022Q4 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
usd
CY2023Q2 us-gaap Dilutive Securities
DilutiveSecurities
usd
CY2022Q2 us-gaap Dilutive Securities
DilutiveSecurities
usd
us-gaap Dilutive Securities
DilutiveSecurities
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000778164

Files In Submission

Name View Source Status
0001213900-23-064551-index-headers.html Edgar Link pending
0001213900-23-064551-index.html Edgar Link pending
0001213900-23-064551.txt Edgar Link pending
0001213900-23-064551-xbrl.zip Edgar Link pending
alto-20230630.xsd Edgar Link pending
f10q0623ex31-1_altoingred.htm Edgar Link pending
f10q0623ex31-2_altoingred.htm Edgar Link pending
f10q0623ex32-1_altoingred.htm Edgar Link pending
f10q0623_altoingred.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
alto-20230630_def.xml Edgar Link unprocessable
alto-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0623_altoingred_htm.xml Edgar Link completed
Show.js Edgar Link pending
alto-20230630_cal.xml Edgar Link unprocessable
alto-20230630_lab.xml Edgar Link unprocessable